Comparing FET Guided by ERA Vs Standard Timing in Patients with Recurrent Implantation Failure

Recruiting N/A Interventional Study
Recurrent Implantation Failure Infertility
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 40
Sex
Female
Study type
Interventional
Purpose
Treatment
Participants needed
734 (estimated)
Sponsor
The University of Hong Kong · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The pregnancy rate of in vitro fertilisation (IVF) remains around 35% per transfer. Women who are not pregnant following several embryo transfers are regarded as having recurrent implantation failure (RIF), with one of the causes being the asynchronization of the embryo and endometrium. Endometrial receptivity analysis (ERA) may identify the window of implantation and guide the timing of embryo tr…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Women with recurrent implantation failure 2. Women aged \< 40 years 3. Body mass index of women between 18.5 (inclusive) and 30 (exclusive) kg/m² 4. Women with at least one high quality frozen blastocyst (BB grade or above) and planning to undergo a single blastocyst transfer…
Contacts

Ernest HY Ng, MD

+85222553400

nghye@hku.hk

CONTACT

Catherine Hung, MBBS

+85296148198

catherinehmw@gmail.com

CONTACT